VCAM1 and Alzheimer disease: Specifically, in AD patients, the levels of ICAM-1, VCAM-1, and E-selectin are higher in comparison to aged-matched controls [142,143] and, in particular, VCAM-1 closely associates with deficiencies in short-term memory, spatial function, and white matter changes, suggesting that it may have important biomarker capabilities [144].